Source link : https://www.newshealth.biz/health-news/study-confirms-no-great-options-for-treating-vexas/
For patients with the auto-inflammatory disease VEXAS, treatment decisions are unfortunately fraught with tradeoffs between effectiveness and risk of adverse effects, a French registry study showed. Among 110 patients in the FRENVEX registry, tumor necrosis factor (TNF) inhibitors were the least effective, with an overall response rate of 15% at 6 months, according to Jerome […]
Author : News Health
Publish date : 2024-05-24 13:43:57
Copyright for syndicated content belongs to the linked Source.